Respiratory Complications in Children and Adolescents with Human Immunodeficiency Virus

Pediatr Clin North Am. 2021 Feb;68(1):131-145. doi: 10.1016/j.pcl.2020.09.016.

Abstract

Respiratory complications comprise a large proportion of the burden of mortality and morbidity in children with human immunodeficiency virus (HIV). HIV-associated lower respiratory tract infection (LRTI) has declined in incidence with early diagnosis and use of antiretroviral therapy (ART) but is widespread in areas with limited access to ART. HIV-exposed uninfected infants have a higher risk of LRTI early in life than unexposed infants. Pulmonary tuberculosis (PTB) presenting as acute or chronic disease is common in highly TB endemic areas. Chronic lung disease is common; preceding LRTI, PTB or late initiation of ART are risk factors.

Keywords: Children; Chronic lung disease; HIV; Lower respiratory tract infection.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / therapy
  • AIDS-Related Opportunistic Infections / virology*
  • Anti-HIV Agents / adverse effects
  • Child
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Immunocompromised Host
  • Lung Diseases / therapy
  • Lung Diseases / virology*

Substances

  • Anti-HIV Agents